# Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

> clinical trial · VERIFIED · 2026-07-16

Status: RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Diabetic Kidney Disease (DKD)

- Company: Regeneron Pharmaceuticals
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07271186

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.